2012
DOI: 10.3390/molecules18010204
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Infectious Agents against MRSA

Abstract: Clinically useful antibiotics, β-lactams and vancomycin, are known to inhibit bacterial cell wall peptidoglycan synthesis. Methicillin-resistant Staphylococcus aureus (MRSA) has a unique cell wall structure consisting of peptidoglycan and wall teichoic acid. In recent years, new anti-infectious agents (spirohexaline, tripropeptin C, DMPI, CDFI, cyslabdan, 1835F03, and BPH-652) targeting MRSA cell wall biosynthesis have been discovered using unique screening methods. These agents were found to inhibit important… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
31
0
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(34 citation statements)
references
References 52 publications
(73 reference statements)
1
31
0
2
Order By: Relevance
“…This information is contained in the mecA gene responsible for encoding an altered PBP (PBP2a). 2,3 Until the early 1990s, MRSA isolates were restricted to hospitals. Currently, however, MRSA is no longer exclusively associated with healthcare infections.…”
Section: Introductionmentioning
confidence: 99%
“…This information is contained in the mecA gene responsible for encoding an altered PBP (PBP2a). 2,3 Until the early 1990s, MRSA isolates were restricted to hospitals. Currently, however, MRSA is no longer exclusively associated with healthcare infections.…”
Section: Introductionmentioning
confidence: 99%
“…This knowledge may contribute not only to the adoption of effective measures to control the infection, but also to the development of new anti-infective drugs that inhibit bacterial growth plus control virulence [12,15].…”
Section: Introductionmentioning
confidence: 99%
“…WTAs are a major polyanionic polymer in the cell walls of S. aureus [121]. Koyama et al [122] discussed several other avenues to target MRSA, including inhibitors of bacterial cell wall peptidoglycan, inhibitors of WTA, and inhibitors of virulence factors such as staphyloxanthin.…”
Section: Treatmentmentioning
confidence: 99%